Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular ...

Boehringer Ingelheim, a German pharmaceutical company, filed a patent infringement lawsuit against Mylan Pharmaceuticals ... version of the plaintiff's product, will violate the plaintiff's ...

Mylan has launched its generic version ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns ...

The case was filed against Mylan Pharmaceuticals Inc, Viatris Speciality, LLC and Viatris Inc., bringing product liability claims in connection with birth control patch Xulane. Xulane, per the ...

Pfizer and Mylan will continue to operate independent entities in Japan, but will collaborate on current and future generic products, sharing the costs and profits. The Japanese pharmaceutical ...

By recommending that children avoid exposure to peanuts until age 3, doctors inadvertently turned a rare issue into a major ...

The agency said it approved Neffy, from ARS Pharmaceuticals ... a pack of two injectors cost $100, but when Mylan bought the ...

Mylan President Rajiv Malik and Emcure Pharmaceuticals CEO Satish Mehta are both named ... among drugmakers to fix prices and allocate customers for at least 15 generic products. Connecticut Attorney ...

(CN) — Global pharmaceutical giant Sanofi-Aventis asked the 10th ... Sanofi claims that rather than offer a better product, Mylan offered extensive discounts to insurers for exclusively covering the ...

Vadodara: Alembic Pharma has announced that Sudhakar Pandiyan has been appointed as Head - Technical Operations (Sterile & ...

Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today that the previously announced cash tender offers (the "Any and All Tender Offers" and each, an "Any and All Tender Offer") of ...

Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular ...